Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

127.22
Delayed Data
As of Sep 23
 -6.47 / -4.84%
Today’s Change
110.56
Today|||52-Week Range
193.45
-33.31%
Year-to-Date

Today’s Trading

Previous close133.69
Today’s open131.60
Day’s range127.18 - 132.30
Volume2,154,637
Average volume (3 months)1,792,450
Market cap$28.5B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)-7.16%
Earnings growth (next 5 years)+24.20%
Revenue growth (last year)+12.25%
P/E ratio424.1
Price/Sales16.57
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.71-1.47%
ZTSZoetis Inc-0.12-0.23%
MYLMylan NV-0.53-1.24%
VRTXVertex Pharmaceutica...-1.49-1.62%
Data as of 4:00pm ET, 09/23/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.17
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts

Search for Jobs